Artificial Intelligence
for Dementia Prevention

What is the challenge?

There are over 50 million people worldwide living with dementia and by 2030 this number is expected to reach 82 million. 

The ageing brain becomes vulnerable to decline and keeping independency in daily life can become a challenge for the elderly. People with Mild Cognitive Impairment (MCI), an intermediate condition between normal brain ageing and dementia, may develop dementia in the future.

There is an urgent need for early risk assessment and intervention. Current practices with time-consuming patient investigations focus on late symptoms management  due to a lack of diagnostic tools. This causes numerous implications in terms of familial, medical and care costs. 

With AI-Mind we aim to reduce the disease’s burden by developing novel, AI-based tools to support healthcare professionals in their diagnosis and offering timely interventions to patients.

The AI-Mind study is a key part of the project and it will:

Take place in Norway, Finland, Italy and Spain and will involve 1,000 participants. 

Help to develop and validate artificial intelligence (AI) based tools to predict who is likely to develop dementia. 

Visit our local study pages to learn more and contact AI-Mind study teams.

Latest News

Norway, Oslo University Hospital

Dr. Ira Haraldsen

Italy, IRCCS San Raffaele Roma

Prof. Paolo Rossini

Italy, Università Cattolica del Sacro Cuore

Prof. Camillo Mara

Finland, Helsinki University Hospital 

Prof. Hanna Renvall

Spain, Complutense University of Madrit 

Prof. Fernando Maestú

An innovative solution for early detection of dementia

AI-Mind

5
Years
15
Partners
5
Hospitals
4
Companies
1
NPO
  • External advisors from ethics, neuroscience, AI, modelling and economics

  • Advocacy groups for patients and physicians

14 M €
Allocated Budget

Dr. Ira Haraldsen

Project Coordinator

Get In touch

Flag icons made by www.flaticon.com